BioWorld Science

Sep. 2, 2019

View Archived Issues

Biogen initiates phase I study of BIIB-094 in patients with Parkinson's disease

Read More

SVI and Janssen extend collaboration agreement with focus on Alzheimer's disease treatment

Read More

Autogramins inhibit the cholesterol-transfer protein GRAMD1A, involved in autophagy regulation

Read More

RIPK1 regulates necrosis of acinar cells in early acute pancreatitis

Read More

New mouse models for human lung infections

Read More

Synthetic oligosaccharide-protein conjugate N. meningitidis vaccine is immunogenic in vivo

Read More

Krystal Biotech initiates phase I/II study of topical KB-105 gene therapy for TGM1-deficient ARCI

Read More

New phase I trial to study gene therapy for APOE4 homozygotes with Alzheimer's disease

Read More

Medshine Discovery divulges new KDM5A inhibitors

Read More

MiR-125a-5p identified as tumor suppressor and biomarker in head and neck cancer

Read More

Ancureall Biomedical Technology identifies CDK9 inhibitors

Read More

Sunshine Lake Pharma discloses BIRC3 inhibitors

Read More

Novel organoid models cover a wide range of endometrial diseases

Read More

Genifarm Laboratories and SCUT patent new compounds for cancer

Read More

Chinese investigators present adenosine A2A receptor antagonists

Read More

New human antibody targeting PSMA inhibits prostate cancer tumor growth

Read More

One and done: Engineered oncolytic virus can invite T cells, feed them lunch

Read More

A reverse engineering approach for in vitro modeling of the human eye

Read More

TLR4 agonist INI-2004 as immunostimulant for the treatment of infectious diseases

Read More

Phase II data reported for P2Y12 inhibitor selatogrel in CAD patients

Read More